Hyperperfusion syndrome after carotid stent angioplasty
I Q Grunwald1, M Politi, W Reith
1Department for Interventional and Diagnostic Neuroradiology, University of the Saarland, Homburg, Germany. i.grunwald@gmx.net
Insights
Hyperperfusion syndrome after carotid artery stenting (CAS) occurred in 2.4% of patients. Preexisting brain lesions significantly increased the risk of developing this complication following CAS.
Area of Science:
- Neurology
- Vascular Surgery
- Radiology
Background:
- Carotid artery stenting (CAS) is a common procedure to treat carotid artery stenosis.
- Hyperperfusion syndrome (HPS) is a rare but serious complication following CAS.
- Understanding the incidence and causes of HPS is crucial for patient safety.
Purpose of the Study:
- To assess the incidence and identify predictors of hyperperfusion syndrome after CAS.
- To investigate the correlation between HPS and various patient characteristics and procedural factors.
Main Methods:
- Retrospective review of 417 patients undergoing CAS.
- Magnetic resonance imaging (MRI) performed pre- and post-CAS in 269 patients.
- Spearman's rho correlation analysis to identify risk factors for HPS.
Main Results:
- HPS occurred in 2.4% (10 cases) of patients with completed MRI.
- Patients with preexisting brain lesions (stroke) had a significantly higher risk of HPS (p=0.022).
- No significant correlation was found between HPS and other patient characteristics analyzed.
Conclusions:
- Extensive microvascular disease may predict HPS after CAS.
- Further research is needed to accurately identify patients at higher risk for HPS.
- Early identification of high-risk patients can help prevent this potentially fatal complication.
Introduction:
This study assesses the incidence and causes of hyperperfusion syndrome occurring after carotid artery stenting (CAS).
Materials And Methods:
We retrospectively reviewed the clinical database of 417 consecutive patients who were treated with CAS in our department to identify patients who developed hyperperfusion syndrome and/or intracranial hemorrhage. Magnetic resonance imaging (MRI) including fluid-attenuated inversion recovery and diffusion-weighted imaging was performed before and after CAS in 269 cases. A Spearman's rho nonparametric correlation was performed to determine whether there was a correlation between the occurrence/development of hyperperfusion syndrome and the patient's age, degree of stenosis on the stented and contralateral side, risk factors such as diabetes, smoking, hypertension, adiposity, gender and fluoroscopy time, and mean area of postprocedural lesions as well as preexisting lesions. Significance was established at p < 0.05.
Results:
Of the 417 carotid arteries stented and where MRI was also completed, we found hyperperfusion syndrome in 2.4% (ten cases). Patients who had preexisting brain lesions (previous or acute stroke) were at a higher risk of developing hyperperfusion syndrome (p = 0.022; Spearman's rho test). We could not validate any correlation with the other patient characteristics.
Conclusion:
Extensive microvascular disease may be a predictor of hyperperfusion syndrome after carotid stent placement. We believe that further studies are warranted to predict more accurately which patients are at greater risk of developing this often fatal complication.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:26Transient Ischemic Attack l: Introduction
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:15Ischemic Stroke ll: Pathophysiology
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:21Cardiac Catheterization II: Right Heart Catheterization